You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK— Interpace Diagnostics announced today that it has signed an agreement with SelectHealth/Intermountain Healthcare to offer its thyroid cancer detection assays to SelectHealth's 850,000 members in Utah and Idaho.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.